Zobrazeno 1 - 10 of 42 pro vyhledávání: '"H.-C. Blossey"'
1
Diagnostische Probleme der Hyperthyreose im höheren Lebensalter
Autor: G. Mayer, J. Köbberling, Dieter Emrich, H. Schicha, H. Dirks, H. C. Blossey, G. Hintze
Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 106:973-978
Seventy-seven patients aged more than 60 years from the iodine deficiency area of southern Lower Saxony with hyperthyroidism, diagnosed by assessment of thyroid parameters, showed a nonspecific disease picture with surprising frequency when compared
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::80c0c87f678a011462c8ab6261b7335d
https://doi.org/10.1055/s-2008-1070436
Zobrazit plný text záznamu
2
Endokrine und Stoffwechselerkrankungen
Autor: H.-C. Blossey
Publikováno v: Klinische Neurologie ISBN: 9783662081198
Klinische Neurologie ISBN: 3540019820
Klinische Neurologie ISBN: 9783642169199
Das hypothalamisch-hypophysare System ist die Schaltstelle zwischen dem ZNS und dem Organismus. Hier werden im ZNS verarbeitete Prozesse in hormonelle Signale umgesetzt, durch die essenzielle Korperfunktionen gesteuert werden. Die Steuerung des Wachs
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb172ece1e5148f4c6075f185e15b1a6
https://doi.org/10.1007/978-3-662-08118-1_52
Zobrazit plný text záznamu
3
Vergleichende Untersuchungen zum Prolaktin-, Östrogen-, Gestagen und Androgenrezeptorgehalt menschlicher Mammakarzinome
Autor: G.A. Nagel, W. Holtkamp, H. C. Blossey, W. Wuttke
Publikováno v: Oncology Research and Treatment. 11:71-76
Ein Rezeptor, der die laktogenen Hormone Prolaktin (mehrerer Spezies) und humanes Wachstumshormon spezifisch, reversibel und mit hoher Affinitat (Kd = 0,23 × 10-10M) bindet, wird in Lebermem-branfraktionen der weiblichen, adulten Ratte nachgewiesen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::29081b0f4516cd59bbceae34f99ec98b
https://doi.org/10.1159/000216491
Zobrazit plný text záznamu
4
Immunhistochemische Untersuchungen zur Bestimmung des Hormonrezeptorstatus von Mammakarzinomen
Autor: Alfred Schauer, H. Rauschecker, R. Brehler, H C Blossey, M. Bergholz
Publikováno v: Klinische Wochenschrift. 64:370-374
Immunohistochemical examinations of 89 breast cancer specimens were performed using two different monoclonal antibodies. One marked the nuclear estrogen-receptor (ER) protein (anti-ER, Abbott), whereas the other marked an ER-related cytoplasmic prote
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::36ec7627e205af25f29141eb179e7a4f
https://doi.org/10.1007/bf01728186
Zobrazit plný text záznamu
5
Megestrolazetat in verschiedenen Dosierungen bei der Behandlung des metastasierenden Mammakarzinoms — Klinische und endokrinologische Untersuchungen
Autor: D. Emrich, G. A. Nagel, H.-E. Wander, H C Blossey
Publikováno v: Klinische Wochenschrift. 63:312-318
Both medroxyprogesterone acetate (MPA) and megestrol acetate (MA) are effective in the treatment of metastatic breast cancer. Although the dose-dependent mode of actions of MPA have been extensively clarified, there is still some uncertainty regardin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0684ed9cfa4a9ad999d4135f01fbc2a8
https://doi.org/10.1007/bf01731974
Zobrazit plný text záznamu
6
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: A phase II study of the association of medical oncology of the German cancer society (AIO)
Autor: H. C. Blossey, H.-E. Wander, Ulrich R. Kleeberg, G. A. Nagel
Publikováno v: Cancer. 58:1985-1989
One hundred twenty-eight women with advanced metastatic breast cancer were treated with a combination of aminoglutethimide (AG) (1000 mg orally, daily) and medroxyprogesterone acetate (MPA) (1500 mg orally, daily for six weeks and thereafter 500 mg o
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c9c678a81260562049cbd13057492966
https://doi.org/10.1002/1097-0142(19861101)58:9<1985::aid-cncr2820580905>3.0.co
Zobrazit plný text záznamu
8
[Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force]
Autor: H E, Wander, G A, Nagel, H C, Blossey
Publikováno v: Onkologie.
In 114 patients with metastatic breast cancer resistant to chemo- and hormonal therapy another attempt was made to treat these patients with the hormone combination of aminoglutethimide (AG) 1000 mg daily and medroxyprogesteroneacetate (MAP) 1500 mg
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4e0a93f897774fa832085e3b0ebc2e41
https://pubmed.ncbi.nlm.nih.gov/6215600
Zobrazit plný text záznamu
9
LIST OF CONTRIBUTORS AND DISCUSSANTS
Autor: H. Adlercreutz, A. Amsterdam, F. Auletta, G.D. Aurbach, K.L. Baird, F.C. Bartter, J.J.M. Bergeron, T. Bigos, L. Birnbaumer, M.E. Birnbaumer, H.-C. Blossey, E.M. Bogdanove, H.L. Bradlow, A.E. Broadus, L. Bullock, H. Burrows, G. Campbell, J. Carter, R. Chatterton, J. Chen, S. Cohen, P.W. Concannon, V. Cortes-Gallegos, C.E. Creutz, K. Crickard, J.F. Crigler, W.F. Crowley, G.B. Cutler, B. Dobyns, P.K. Donahoe, R.W. Downs, B. Dupont, J. Dupre, C. Eil, J. Eng, L.E. Faber, R. Fellows, J.S. Flier, H.G. Friesen, T. Fujii, J. Geller, F.W. George, J.M. George, A.L. Goldstein, R.O. Greep, J.E. Griffin, W.W. Grody, M.M. Grumbach, C. Grunfeld, N. Hall, J.T. Harmon, L.C. Harrison, S. Hu, M.R. Hughes, I.T. Huhtaniemi, R.B. Jaffe, R. Jewelewicz, Z. Josefsberg, C.R. Kahn, F.A. Karlsson, F.J. Karsch, M. Kasuga, M.N. Khan, R.J. Khan, G.L. King, E. Knobil, D. Koritnik, W. Krawietz, G.E. Landreth, U.C. Lang, C. Lazier, M. Leshin, L.S. Levine, M.A. Levine, T.L.K. Low, J.E. McClure, G. Macdonald, T.J. McDonald, S.J. Marx, A.R. Means, R.E. Miller, B.F. Mitchell, C. Monder, I. Mowszowicz, W.R. Moyle, B.E.P. Murphy, T. Murray, F. Naftolin, Z. Naor, P.B. Naylor, M.I. New, J. Nolin, W.D. Odell, B.W. O'Malley, S. Pang, J. Parsons, B.A. Patel, C.J. Pazoles, O.H. Pearson, E. Peck, G.J. Pepe, J.M. Podskalny, M. Pollack, H.B. Pollard, B.I. Posner, M. Postel-Vinay, C. Raj, H.G.M. Raj, J.E. Rall, S.A. Reen, B.F. Rice, H.J. Ringold, B. Robaire, I. Rothchild, A.K. Roy, S.W. Ryder, P.H. Saenger, K. Savard, W.T. Schrader, M. Serón-Ferré, E.M. Shooter, R.A. Sikstrom, M.J. Singer, S.W. Spaulding, A.M. Spiegel, B.G. Steinetz, K. Sterling, E. Straus, A. Sutter, G.B. Thurman, W.P. VanderLaan, E. Van Obberghen, A.K. Verma, R.F. Weick, N.L. Weigel, G. Weiss, J. Weisz, A. Wentz, J.D. Wilson, C.A. Winkel, C.J. Woodard, R.S. Yalow, B.A. Yankner, M.M. Zatz
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939ff0a3e72d0a1df500e3f4fdb90967
https://doi.org/10.1016/b978-0-12-571135-7.50003-5
Zobrazit plný text záznamu
10
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate
Autor: H C, Blossey, H E, Wander, J, Koebberling, G A, Nagel
Publikováno v: Cancer. 54
Postmenopausal patients with metastatic breast cancer were treated with medroxyprogesterone acetate (MPA) (Clinovir) in dosages between 500 and 1500 mg orally per day. The relation of MPA plasma concentrations and endocrine effects were studied in a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0dae924d62f437b120abeac67a4a1675
https://pubmed.ncbi.nlm.nih.gov/6088020
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje